nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—SLC22A5—Dactinomycin—skin cancer	0.127	0.161	CbGbCtD
Norfloxacin—CYP1A2—Imiquimod—skin cancer	0.101	0.129	CbGbCtD
Norfloxacin—CYP1A1—Dacarbazine—skin cancer	0.0951	0.121	CbGbCtD
Norfloxacin—CYP2A6—Fluorouracil—skin cancer	0.0653	0.083	CbGbCtD
Norfloxacin—CYP1A2—Vemurafenib—skin cancer	0.0555	0.0705	CbGbCtD
Norfloxacin—CYP3A4—Imiquimod—skin cancer	0.053	0.0674	CbGbCtD
Norfloxacin—CYP3A4—Temozolomide—skin cancer	0.053	0.0674	CbGbCtD
Norfloxacin—CYP1A2—Dacarbazine—skin cancer	0.0425	0.054	CbGbCtD
Norfloxacin—CYP3A4—Vismodegib—skin cancer	0.0368	0.0467	CbGbCtD
Norfloxacin—CYP3A7—Docetaxel—skin cancer	0.0341	0.0433	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0341	0.0433	CbGbCtD
Norfloxacin—CYP3A4—Vemurafenib—skin cancer	0.0291	0.0369	CbGbCtD
Norfloxacin—CYP3A5—Docetaxel—skin cancer	0.0256	0.0325	CbGbCtD
Norfloxacin—CYP1A2—Fluorouracil—skin cancer	0.0249	0.0317	CbGbCtD
Norfloxacin—CYP3A4—Docetaxel—skin cancer	0.00997	0.0127	CbGbCtD
Norfloxacin—TOP2A—Sorafenib—Vismodegib—skin cancer	0.00263	0.584	CbGdCrCtD
Norfloxacin—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.00188	0.416	CbGdCrCtD
Norfloxacin—Oedema—Imiquimod—skin cancer	0.000514	0.00246	CcSEcCtD
Norfloxacin—Lightheadedness—Docetaxel—skin cancer	0.000513	0.00246	CcSEcCtD
Norfloxacin—Hypoaesthesia—Bleomycin—skin cancer	0.000511	0.00245	CcSEcCtD
Norfloxacin—Neutropenia—Temozolomide—skin cancer	0.000506	0.00243	CcSEcCtD
Norfloxacin—Dysphagia—Fluorouracil—skin cancer	0.000499	0.00239	CcSEcCtD
Norfloxacin—Agranulocytosis—Dactinomycin—skin cancer	0.000498	0.00239	CcSEcCtD
Norfloxacin—Hyperhidrosis—Imiquimod—skin cancer	0.000497	0.00238	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Temozolomide—skin cancer	0.000494	0.00237	CcSEcCtD
Norfloxacin—Eosinophilia—Fluorouracil—skin cancer	0.000494	0.00237	CcSEcCtD
Norfloxacin—Anorexia—Imiquimod—skin cancer	0.00049	0.00235	CcSEcCtD
Norfloxacin—Hepatitis—Dactinomycin—skin cancer	0.000479	0.0023	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000479	0.0023	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000479	0.0023	CcSEcCtD
Norfloxacin—Body temperature increased—Vemurafenib—skin cancer	0.000476	0.00228	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Temozolomide—skin cancer	0.000473	0.00227	CcSEcCtD
Norfloxacin—Swelling—Docetaxel—skin cancer	0.000472	0.00226	CcSEcCtD
Norfloxacin—Stomatitis—Temozolomide—skin cancer	0.000471	0.00226	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000468	0.00225	CcSEcCtD
Norfloxacin—Deafness—Docetaxel—skin cancer	0.000466	0.00223	CcSEcCtD
Norfloxacin—Insomnia—Imiquimod—skin cancer	0.000465	0.00223	CcSEcCtD
Norfloxacin—Hepatic failure—Docetaxel—skin cancer	0.000464	0.00222	CcSEcCtD
Norfloxacin—Paraesthesia—Imiquimod—skin cancer	0.000461	0.00221	CcSEcCtD
Norfloxacin—Chills—Bleomycin—skin cancer	0.000461	0.00221	CcSEcCtD
Norfloxacin—Dyspnoea—Imiquimod—skin cancer	0.000458	0.0022	CcSEcCtD
Norfloxacin—Somnolence—Imiquimod—skin cancer	0.000457	0.00219	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Fluorouracil—skin cancer	0.000455	0.00218	CcSEcCtD
Norfloxacin—Erythema multiforme—Dactinomycin—skin cancer	0.000453	0.00217	CcSEcCtD
Norfloxacin—Dyspepsia—Imiquimod—skin cancer	0.000452	0.00217	CcSEcCtD
Norfloxacin—Erythema—Bleomycin—skin cancer	0.000447	0.00214	CcSEcCtD
Norfloxacin—Decreased appetite—Imiquimod—skin cancer	0.000447	0.00214	CcSEcCtD
Norfloxacin—Hypersensitivity—Vemurafenib—skin cancer	0.000444	0.00213	CcSEcCtD
Norfloxacin—Fatigue—Imiquimod—skin cancer	0.000443	0.00212	CcSEcCtD
Norfloxacin—Visual disturbance—Docetaxel—skin cancer	0.00044	0.00211	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Fluorouracil—skin cancer	0.000438	0.0021	CcSEcCtD
Norfloxacin—Myocardial infarction—Fluorouracil—skin cancer	0.000436	0.00209	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000436	0.00209	CcSEcCtD
Norfloxacin—Dermatitis bullous—Docetaxel—skin cancer	0.000436	0.00209	CcSEcCtD
Norfloxacin—Stomatitis—Fluorouracil—skin cancer	0.000434	0.00208	CcSEcCtD
Norfloxacin—Hepatitis—Temozolomide—skin cancer	0.000433	0.00208	CcSEcCtD
Norfloxacin—Conjunctivitis—Fluorouracil—skin cancer	0.000432	0.00207	CcSEcCtD
Norfloxacin—Asthenia—Vemurafenib—skin cancer	0.000432	0.00207	CcSEcCtD
Norfloxacin—Hypoaesthesia—Temozolomide—skin cancer	0.000431	0.00207	CcSEcCtD
Norfloxacin—Hallucination—Temozolomide—skin cancer	0.000431	0.00207	CcSEcCtD
Norfloxacin—Chills—Dactinomycin—skin cancer	0.00043	0.00206	CcSEcCtD
Norfloxacin—Pruritus—Vemurafenib—skin cancer	0.000426	0.00204	CcSEcCtD
Norfloxacin—Feeling abnormal—Imiquimod—skin cancer	0.000423	0.00203	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Imiquimod—skin cancer	0.00042	0.00201	CcSEcCtD
Norfloxacin—Visual impairment—Temozolomide—skin cancer	0.000418	0.002	CcSEcCtD
Norfloxacin—Erythema—Dactinomycin—skin cancer	0.000417	0.002	CcSEcCtD
Norfloxacin—Agranulocytosis—Fluorouracil—skin cancer	0.000415	0.00199	CcSEcCtD
Norfloxacin—Diarrhoea—Vemurafenib—skin cancer	0.000412	0.00198	CcSEcCtD
Norfloxacin—Erythema multiforme—Temozolomide—skin cancer	0.00041	0.00197	CcSEcCtD
Norfloxacin—Urticaria—Imiquimod—skin cancer	0.000408	0.00196	CcSEcCtD
Norfloxacin—Body temperature increased—Imiquimod—skin cancer	0.000406	0.00195	CcSEcCtD
Norfloxacin—Abdominal pain—Imiquimod—skin cancer	0.000406	0.00195	CcSEcCtD
Norfloxacin—Tinnitus—Temozolomide—skin cancer	0.000404	0.00194	CcSEcCtD
Norfloxacin—Leukopenia—Bleomycin—skin cancer	0.0004	0.00192	CcSEcCtD
Norfloxacin—Dizziness—Vemurafenib—skin cancer	0.000398	0.00191	CcSEcCtD
Norfloxacin—Hypoaesthesia—Fluorouracil—skin cancer	0.000397	0.00191	CcSEcCtD
Norfloxacin—Ataxia—Docetaxel—skin cancer	0.000392	0.00188	CcSEcCtD
Norfloxacin—Chills—Temozolomide—skin cancer	0.000389	0.00186	CcSEcCtD
Norfloxacin—Liver function test abnormal—Docetaxel—skin cancer	0.000385	0.00184	CcSEcCtD
Norfloxacin—Vomiting—Vemurafenib—skin cancer	0.000383	0.00184	CcSEcCtD
Norfloxacin—Chest pain—Bleomycin—skin cancer	0.000381	0.00183	CcSEcCtD
Norfloxacin—Myalgia—Bleomycin—skin cancer	0.000381	0.00183	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Docetaxel—skin cancer	0.00038	0.00182	CcSEcCtD
Norfloxacin—Rash—Vemurafenib—skin cancer	0.00038	0.00182	CcSEcCtD
Norfloxacin—Dermatitis—Vemurafenib—skin cancer	0.000379	0.00182	CcSEcCtD
Norfloxacin—Hypersensitivity—Imiquimod—skin cancer	0.000379	0.00182	CcSEcCtD
Norfloxacin—Headache—Vemurafenib—skin cancer	0.000377	0.00181	CcSEcCtD
Norfloxacin—Erythema—Temozolomide—skin cancer	0.000377	0.00181	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000375	0.0018	CcSEcCtD
Norfloxacin—Cramp muscle—Docetaxel—skin cancer	0.000375	0.0018	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000375	0.0018	CcSEcCtD
Norfloxacin—Leukopenia—Dactinomycin—skin cancer	0.000373	0.00179	CcSEcCtD
Norfloxacin—Dysgeusia—Temozolomide—skin cancer	0.000369	0.00177	CcSEcCtD
Norfloxacin—Asthenia—Imiquimod—skin cancer	0.000369	0.00177	CcSEcCtD
Norfloxacin—Confusional state—Bleomycin—skin cancer	0.000368	0.00177	CcSEcCtD
Norfloxacin—Anaphylactic shock—Bleomycin—skin cancer	0.000365	0.00175	CcSEcCtD
Norfloxacin—Oedema—Bleomycin—skin cancer	0.000365	0.00175	CcSEcCtD
Norfloxacin—Back pain—Temozolomide—skin cancer	0.000365	0.00175	CcSEcCtD
Norfloxacin—Pruritus—Imiquimod—skin cancer	0.000363	0.00174	CcSEcCtD
Norfloxacin—Dysphagia—Docetaxel—skin cancer	0.00036	0.00173	CcSEcCtD
Norfloxacin—Nausea—Vemurafenib—skin cancer	0.000358	0.00172	CcSEcCtD
Norfloxacin—Thrombocytopenia—Bleomycin—skin cancer	0.000357	0.00171	CcSEcCtD
Norfloxacin—Vision blurred—Temozolomide—skin cancer	0.000356	0.00171	CcSEcCtD
Norfloxacin—Myalgia—Dactinomycin—skin cancer	0.000355	0.0017	CcSEcCtD
Norfloxacin—Tremor—Temozolomide—skin cancer	0.000353	0.0017	CcSEcCtD
Norfloxacin—Diarrhoea—Imiquimod—skin cancer	0.000352	0.00169	CcSEcCtD
Norfloxacin—Anorexia—Bleomycin—skin cancer	0.000348	0.00167	CcSEcCtD
Norfloxacin—Erythema—Fluorouracil—skin cancer	0.000348	0.00167	CcSEcCtD
Norfloxacin—Agitation—Temozolomide—skin cancer	0.000347	0.00166	CcSEcCtD
Norfloxacin—Angioedema—Temozolomide—skin cancer	0.000345	0.00165	CcSEcCtD
Norfloxacin—Oedema—Dactinomycin—skin cancer	0.00034	0.00163	CcSEcCtD
Norfloxacin—Dizziness—Imiquimod—skin cancer	0.00034	0.00163	CcSEcCtD
Norfloxacin—Vertigo—Temozolomide—skin cancer	0.000339	0.00163	CcSEcCtD
Norfloxacin—Leukopenia—Temozolomide—skin cancer	0.000338	0.00162	CcSEcCtD
Norfloxacin—Neutropenia—Docetaxel—skin cancer	0.000337	0.00161	CcSEcCtD
Norfloxacin—Palpitations—Temozolomide—skin cancer	0.000333	0.0016	CcSEcCtD
Norfloxacin—Thrombocytopenia—Dactinomycin—skin cancer	0.000333	0.0016	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000333	0.00159	CcSEcCtD
Norfloxacin—Paraesthesia—Bleomycin—skin cancer	0.000328	0.00157	CcSEcCtD
Norfloxacin—Vision blurred—Fluorouracil—skin cancer	0.000328	0.00157	CcSEcCtD
Norfloxacin—Convulsion—Temozolomide—skin cancer	0.000327	0.00157	CcSEcCtD
Norfloxacin—Vomiting—Imiquimod—skin cancer	0.000327	0.00157	CcSEcCtD
Norfloxacin—Dyspnoea—Bleomycin—skin cancer	0.000325	0.00156	CcSEcCtD
Norfloxacin—Anorexia—Dactinomycin—skin cancer	0.000324	0.00156	CcSEcCtD
Norfloxacin—Rash—Imiquimod—skin cancer	0.000324	0.00155	CcSEcCtD
Norfloxacin—Dermatitis—Imiquimod—skin cancer	0.000324	0.00155	CcSEcCtD
Norfloxacin—Headache—Imiquimod—skin cancer	0.000322	0.00154	CcSEcCtD
Norfloxacin—Myalgia—Temozolomide—skin cancer	0.000321	0.00154	CcSEcCtD
Norfloxacin—Arthralgia—Temozolomide—skin cancer	0.000321	0.00154	CcSEcCtD
Norfloxacin—Anxiety—Temozolomide—skin cancer	0.00032	0.00154	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000318	0.00153	CcSEcCtD
Norfloxacin—Decreased appetite—Bleomycin—skin cancer	0.000317	0.00152	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Docetaxel—skin cancer	0.000316	0.00152	CcSEcCtD
Norfloxacin—Renal failure—Docetaxel—skin cancer	0.000316	0.00151	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Docetaxel—skin cancer	0.000315	0.00151	CcSEcCtD
Norfloxacin—Myocardial infarction—Docetaxel—skin cancer	0.000315	0.00151	CcSEcCtD
Norfloxacin—Dry mouth—Temozolomide—skin cancer	0.000314	0.00151	CcSEcCtD
Norfloxacin—Jaundice—Docetaxel—skin cancer	0.000313	0.0015	CcSEcCtD
Norfloxacin—Stomatitis—Docetaxel—skin cancer	0.000313	0.0015	CcSEcCtD
Norfloxacin—Conjunctivitis—Docetaxel—skin cancer	0.000312	0.0015	CcSEcCtD
Norfloxacin—Leukopenia—Fluorouracil—skin cancer	0.000311	0.00149	CcSEcCtD
Norfloxacin—Confusional state—Temozolomide—skin cancer	0.00031	0.00149	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00031	0.00149	CcSEcCtD
Norfloxacin—Anaphylactic shock—Temozolomide—skin cancer	0.000308	0.00148	CcSEcCtD
Norfloxacin—Oedema—Temozolomide—skin cancer	0.000308	0.00148	CcSEcCtD
Norfloxacin—Nausea—Imiquimod—skin cancer	0.000305	0.00146	CcSEcCtD
Norfloxacin—Thrombocytopenia—Temozolomide—skin cancer	0.000301	0.00145	CcSEcCtD
Norfloxacin—Convulsion—Fluorouracil—skin cancer	0.000301	0.00144	CcSEcCtD
Norfloxacin—Feeling abnormal—Bleomycin—skin cancer	0.000301	0.00144	CcSEcCtD
Norfloxacin—Agranulocytosis—Docetaxel—skin cancer	0.0003	0.00144	CcSEcCtD
Norfloxacin—Hyperhidrosis—Temozolomide—skin cancer	0.000298	0.00143	CcSEcCtD
Norfloxacin—Chest pain—Fluorouracil—skin cancer	0.000296	0.00142	CcSEcCtD
Norfloxacin—Myalgia—Fluorouracil—skin cancer	0.000296	0.00142	CcSEcCtD
Norfloxacin—Decreased appetite—Dactinomycin—skin cancer	0.000296	0.00142	CcSEcCtD
Norfloxacin—Fatigue—Dactinomycin—skin cancer	0.000293	0.00141	CcSEcCtD
Norfloxacin—Anorexia—Temozolomide—skin cancer	0.000293	0.00141	CcSEcCtD
Norfloxacin—Urticaria—Bleomycin—skin cancer	0.00029	0.00139	CcSEcCtD
Norfloxacin—Body temperature increased—Bleomycin—skin cancer	0.000289	0.00138	CcSEcCtD
Norfloxacin—Hepatitis—Docetaxel—skin cancer	0.000288	0.00138	CcSEcCtD
Norfloxacin—Hypoaesthesia—Docetaxel—skin cancer	0.000287	0.00138	CcSEcCtD
Norfloxacin—Confusional state—Fluorouracil—skin cancer	0.000286	0.00137	CcSEcCtD
Norfloxacin—Oedema—Fluorouracil—skin cancer	0.000284	0.00136	CcSEcCtD
Norfloxacin—Anaphylactic shock—Fluorouracil—skin cancer	0.000284	0.00136	CcSEcCtD
Norfloxacin—Feeling abnormal—Dactinomycin—skin cancer	0.000281	0.00135	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000281	0.00135	CcSEcCtD
Norfloxacin—Insomnia—Temozolomide—skin cancer	0.000278	0.00134	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000278	0.00134	CcSEcCtD
Norfloxacin—Thrombocytopenia—Fluorouracil—skin cancer	0.000278	0.00133	CcSEcCtD
Norfloxacin—Visual impairment—Docetaxel—skin cancer	0.000278	0.00133	CcSEcCtD
Norfloxacin—Paraesthesia—Temozolomide—skin cancer	0.000276	0.00133	CcSEcCtD
Norfloxacin—Dyspnoea—Temozolomide—skin cancer	0.000274	0.00132	CcSEcCtD
Norfloxacin—Somnolence—Temozolomide—skin cancer	0.000274	0.00131	CcSEcCtD
Norfloxacin—Erythema multiforme—Docetaxel—skin cancer	0.000272	0.00131	CcSEcCtD
Norfloxacin—Dyspepsia—Temozolomide—skin cancer	0.000271	0.0013	CcSEcCtD
Norfloxacin—Anorexia—Fluorouracil—skin cancer	0.00027	0.0013	CcSEcCtD
Norfloxacin—Body temperature increased—Dactinomycin—skin cancer	0.000269	0.00129	CcSEcCtD
Norfloxacin—Abdominal pain—Dactinomycin—skin cancer	0.000269	0.00129	CcSEcCtD
Norfloxacin—Hypersensitivity—Bleomycin—skin cancer	0.000269	0.00129	CcSEcCtD
Norfloxacin—Decreased appetite—Temozolomide—skin cancer	0.000268	0.00128	CcSEcCtD
Norfloxacin—Fatigue—Temozolomide—skin cancer	0.000265	0.00127	CcSEcCtD
Norfloxacin—Constipation—Temozolomide—skin cancer	0.000263	0.00126	CcSEcCtD
Norfloxacin—Asthenia—Bleomycin—skin cancer	0.000262	0.00126	CcSEcCtD
Norfloxacin—Chills—Docetaxel—skin cancer	0.000259	0.00124	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000258	0.00124	CcSEcCtD
Norfloxacin—Pruritus—Bleomycin—skin cancer	0.000258	0.00124	CcSEcCtD
Norfloxacin—Insomnia—Fluorouracil—skin cancer	0.000257	0.00123	CcSEcCtD
Norfloxacin—Paraesthesia—Fluorouracil—skin cancer	0.000255	0.00122	CcSEcCtD
Norfloxacin—Feeling abnormal—Temozolomide—skin cancer	0.000254	0.00122	CcSEcCtD
Norfloxacin—Dyspnoea—Fluorouracil—skin cancer	0.000253	0.00121	CcSEcCtD
Norfloxacin—Somnolence—Fluorouracil—skin cancer	0.000252	0.00121	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Temozolomide—skin cancer	0.000252	0.00121	CcSEcCtD
Norfloxacin—Erythema—Docetaxel—skin cancer	0.000251	0.0012	CcSEcCtD
Norfloxacin—Hypersensitivity—Dactinomycin—skin cancer	0.000251	0.0012	CcSEcCtD
Norfloxacin—Dyspepsia—Fluorouracil—skin cancer	0.00025	0.0012	CcSEcCtD
Norfloxacin—Decreased appetite—Fluorouracil—skin cancer	0.000247	0.00118	CcSEcCtD
Norfloxacin—Dysgeusia—Docetaxel—skin cancer	0.000246	0.00118	CcSEcCtD
Norfloxacin—Urticaria—Temozolomide—skin cancer	0.000245	0.00117	CcSEcCtD
Norfloxacin—Asthenia—Dactinomycin—skin cancer	0.000244	0.00117	CcSEcCtD
Norfloxacin—Abdominal pain—Temozolomide—skin cancer	0.000243	0.00117	CcSEcCtD
Norfloxacin—Body temperature increased—Temozolomide—skin cancer	0.000243	0.00117	CcSEcCtD
Norfloxacin—Back pain—Docetaxel—skin cancer	0.000243	0.00116	CcSEcCtD
Norfloxacin—Muscle spasms—Docetaxel—skin cancer	0.000241	0.00116	CcSEcCtD
Norfloxacin—Feeling abnormal—Fluorouracil—skin cancer	0.000234	0.00112	CcSEcCtD
Norfloxacin—Diarrhoea—Dactinomycin—skin cancer	0.000233	0.00112	CcSEcCtD
Norfloxacin—Vomiting—Bleomycin—skin cancer	0.000232	0.00111	CcSEcCtD
Norfloxacin—Rash—Bleomycin—skin cancer	0.00023	0.0011	CcSEcCtD
Norfloxacin—Dermatitis—Bleomycin—skin cancer	0.00023	0.0011	CcSEcCtD
Norfloxacin—Hypersensitivity—Temozolomide—skin cancer	0.000227	0.00109	CcSEcCtD
Norfloxacin—Urticaria—Fluorouracil—skin cancer	0.000225	0.00108	CcSEcCtD
Norfloxacin—Leukopenia—Docetaxel—skin cancer	0.000225	0.00108	CcSEcCtD
Norfloxacin—Body temperature increased—Fluorouracil—skin cancer	0.000224	0.00108	CcSEcCtD
Norfloxacin—Palpitations—Docetaxel—skin cancer	0.000222	0.00106	CcSEcCtD
Norfloxacin—Asthenia—Temozolomide—skin cancer	0.000221	0.00106	CcSEcCtD
Norfloxacin—Pruritus—Temozolomide—skin cancer	0.000218	0.00104	CcSEcCtD
Norfloxacin—Convulsion—Docetaxel—skin cancer	0.000217	0.00104	CcSEcCtD
Norfloxacin—Nausea—Bleomycin—skin cancer	0.000217	0.00104	CcSEcCtD
Norfloxacin—Vomiting—Dactinomycin—skin cancer	0.000216	0.00104	CcSEcCtD
Norfloxacin—Rash—Dactinomycin—skin cancer	0.000215	0.00103	CcSEcCtD
Norfloxacin—Chest pain—Docetaxel—skin cancer	0.000214	0.00102	CcSEcCtD
Norfloxacin—Arthralgia—Docetaxel—skin cancer	0.000214	0.00102	CcSEcCtD
Norfloxacin—Myalgia—Docetaxel—skin cancer	0.000214	0.00102	CcSEcCtD
Norfloxacin—Diarrhoea—Temozolomide—skin cancer	0.000211	0.00101	CcSEcCtD
Norfloxacin—Hypersensitivity—Fluorouracil—skin cancer	0.000209	0.001	CcSEcCtD
Norfloxacin—Dry mouth—Docetaxel—skin cancer	0.000209	0.001	CcSEcCtD
Norfloxacin—Confusional state—Docetaxel—skin cancer	0.000206	0.00099	CcSEcCtD
Norfloxacin—Anaphylactic shock—Docetaxel—skin cancer	0.000205	0.000982	CcSEcCtD
Norfloxacin—Oedema—Docetaxel—skin cancer	0.000205	0.000982	CcSEcCtD
Norfloxacin—Dizziness—Temozolomide—skin cancer	0.000204	0.000976	CcSEcCtD
Norfloxacin—Nausea—Dactinomycin—skin cancer	0.000202	0.00097	CcSEcCtD
Norfloxacin—Pruritus—Fluorouracil—skin cancer	0.000201	0.000963	CcSEcCtD
Norfloxacin—Thrombocytopenia—Docetaxel—skin cancer	0.0002	0.000961	CcSEcCtD
Norfloxacin—Vomiting—Temozolomide—skin cancer	0.000196	0.000939	CcSEcCtD
Norfloxacin—Anorexia—Docetaxel—skin cancer	0.000195	0.000936	CcSEcCtD
Norfloxacin—Rash—Temozolomide—skin cancer	0.000194	0.000931	CcSEcCtD
Norfloxacin—Diarrhoea—Fluorouracil—skin cancer	0.000194	0.000931	CcSEcCtD
Norfloxacin—Dermatitis—Temozolomide—skin cancer	0.000194	0.00093	CcSEcCtD
Norfloxacin—Headache—Temozolomide—skin cancer	0.000193	0.000925	CcSEcCtD
Norfloxacin—Dizziness—Fluorouracil—skin cancer	0.000188	0.0009	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000187	0.000895	CcSEcCtD
Norfloxacin—Insomnia—Docetaxel—skin cancer	0.000185	0.000888	CcSEcCtD
Norfloxacin—Paraesthesia—Docetaxel—skin cancer	0.000184	0.000882	CcSEcCtD
Norfloxacin—Nausea—Temozolomide—skin cancer	0.000183	0.000877	CcSEcCtD
Norfloxacin—Dyspnoea—Docetaxel—skin cancer	0.000183	0.000876	CcSEcCtD
Norfloxacin—Somnolence—Docetaxel—skin cancer	0.000182	0.000873	CcSEcCtD
Norfloxacin—Vomiting—Fluorouracil—skin cancer	0.00018	0.000865	CcSEcCtD
Norfloxacin—Dyspepsia—Docetaxel—skin cancer	0.00018	0.000864	CcSEcCtD
Norfloxacin—Rash—Fluorouracil—skin cancer	0.000179	0.000858	CcSEcCtD
Norfloxacin—Dermatitis—Fluorouracil—skin cancer	0.000179	0.000857	CcSEcCtD
Norfloxacin—Decreased appetite—Docetaxel—skin cancer	0.000178	0.000854	CcSEcCtD
Norfloxacin—Headache—Fluorouracil—skin cancer	0.000178	0.000852	CcSEcCtD
Norfloxacin—Fatigue—Docetaxel—skin cancer	0.000177	0.000847	CcSEcCtD
Norfloxacin—Constipation—Docetaxel—skin cancer	0.000175	0.00084	CcSEcCtD
Norfloxacin—Feeling abnormal—Docetaxel—skin cancer	0.000169	0.000809	CcSEcCtD
Norfloxacin—Nausea—Fluorouracil—skin cancer	0.000168	0.000808	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Docetaxel—skin cancer	0.000167	0.000803	CcSEcCtD
Norfloxacin—Abdominal pain—Docetaxel—skin cancer	0.000162	0.000776	CcSEcCtD
Norfloxacin—Body temperature increased—Docetaxel—skin cancer	0.000162	0.000776	CcSEcCtD
Norfloxacin—Hypersensitivity—Docetaxel—skin cancer	0.000151	0.000724	CcSEcCtD
Norfloxacin—Asthenia—Docetaxel—skin cancer	0.000147	0.000705	CcSEcCtD
Norfloxacin—Pruritus—Docetaxel—skin cancer	0.000145	0.000695	CcSEcCtD
Norfloxacin—Diarrhoea—Docetaxel—skin cancer	0.00014	0.000672	CcSEcCtD
Norfloxacin—Dizziness—Docetaxel—skin cancer	0.000135	0.000649	CcSEcCtD
Norfloxacin—Vomiting—Docetaxel—skin cancer	0.00013	0.000624	CcSEcCtD
Norfloxacin—Rash—Docetaxel—skin cancer	0.000129	0.000619	CcSEcCtD
Norfloxacin—Dermatitis—Docetaxel—skin cancer	0.000129	0.000619	CcSEcCtD
Norfloxacin—Headache—Docetaxel—skin cancer	0.000128	0.000615	CcSEcCtD
Norfloxacin—Nausea—Docetaxel—skin cancer	0.000122	0.000583	CcSEcCtD
